Erectile dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 20-60 years, male; 2) General health, stable heterosexual partner for more than 3 months; 3) Mild to moderate ED (IIEF-EF between 11 and 25) or severe ED (IIEF-EF less than 11); 4) ED with a history of at least 3 months and less than 10 years; 5) Patients who did not use PDE5-I or other ED treatment methods within 2 weeks before grouping; 6) The patient voluntarily agreed to participate in this study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) Secretory ED or neurogenic ED caused by severe endocrine disorders or sex hormone abnormalities; 2) Vascular ED caused by penile artery and cavernous lesions; 3) Any person with severe mental illness, spinal cord injury, abnormal penile anatomy, or penile hemangioma; 4) Poor blood pressure control in hypertensive patients (systolic blood pressure >= 160 mmHg and diastolic blood pressure >= 100 mmHg after treatment); 5) Diabetic blood glucose control was poor, and fasting plasma glucose (FPG) level was >7.0 mmol/l(126 mg/dl); 6) Clinically significant chronic diseases of the blood system, or severe respiratory, digestive and neurocentral diseases; 7) Patients who have had radical prostatectomy, pelvic surgery or radical prostate cancer surgery in the past; 8) Recovering from cancer in the past 1 year, or having undergone radiotherapy in the pelvic region; 9) Use anti-androgen and androgen drugs; Coagulation disorders and the use of anticoagulant agents (such as Coumadin) medicated ED; 10) Has participated in any other medical device or drug clinical investigator in the past 3 months; Or other patients whom the investigator considers inappropriate for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IIEF-EF; | — |
Secondary
| Measure | Time frame |
|---|---|
| SEP;GAQ;EHS;Adverse Event; | — |
Countries
China
Contacts
Shanghai General Hospital